← Leaderboards
Justin Blaine Schaal
University Of Southern California
$3,025,760
Attributed
$3,025,760
Total exposure
1
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1M · FY2023–25$2M$1.5M$1M$500K$0
'23
'24
'25
Funding mix
By agency
NIH$3,025,760 · 1
By mechanism
R01$3,025,760 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- Timothy Jay Bensman$82,416
Others in their field
Other Rising Stars on “Carbapenems”
- Paul Sebahar · Curza Inc$2,858,436
- Zackery P. Bulman · University Of Illinois At Chicago$2,461,528
- Tsuyoshi Uehara · Venatorx Pharmaceuticals, Inc.$2,000,000
- Yanan Zhao · State University Of New York At Buffalo$1,596,741
- Medini K Annavajhala · Columbia University Health Sciences$1,283,298
- Yinzhi Lang · University Of Florida$1,261,878
Research focus
CarbapenemsAntibioticsAdme StudyAcinetobacter BaumanniiAntibody TestAnti-Infective AgentsAntimicrobialAntibiotic TherapyAntibodiesApplications GrantsBacteremiaBacteriaBacterial Antibiotic ResistanceBacterial InfectionsBacterial ModelBacterial ResistanceBiochemical PathwayBiologicalBiologyBloodCanis FamiliarisCarbapenem ResistanceCarbapenem-Resistant EnterobacteriaceaeCell Communication
Grant awards (3)
Host Directed Orynotide for MDR Gram Negative Bacterial Infections$1,023,350
R01 · FY2025 · AI · contact PI
Host Directed Orynotide for MDR Gram Negative Bacterial Infections$996,458
R01 · FY2024 · AI · contact PI
Host Directed Orynotide for MDR Gram Negative Bacterial Infections$1,005,952
R01 · FY2023 · AI · contact PI